Pomegranate Juice Does Not Impair Clearance of Oral or Intravenous Midazolam, a Probe for Cytochrome P450‐3A Activity: Comparison With Grapefruit Juice

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of clinical pharmacology

• Publication date

  2007-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1177/0091270006298359PMID 17322140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variation in Furanocoumarin Content and New Furanocoumarin Dimers in Commercial Grapefruit (Citrus paradisi Macf.) Juices

  2006cited by this paper
• Rhabdomyolysis associated with pomegranate juice consumption.

  2006cited by this paper
• Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia

  2006cited by this paper
• Grapefruit‐Drug Interactions: Can Interactions With Drugs Be Avoided?

  2006cited by this paper
• A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction.

  2006cited by this paper
• PI‐63

  2006cited by this paper
• Furocoumarins from grapefruit juice and their effect on human CYP 3A4 and CYP 1B1 isoenzymes.

  2006cited by this paper
• Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: Comparison with ritonavir

  2006cited by this paper
• EFFECTS OF POMEGRANATE JUICE ON HUMAN CYTOCHROME P450 3A (CYP3A) AND CARBAMAZEPINE PHARMACOKINETICS IN RATS

  2005influential reference
• Two Major Grapefruit Juice Components Differ in Time to Onset of Intestinal CYP3A4 Inhibition

  2005cited by this paper
• Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide

  2004cited by this paper
• Inhibition of human cytochromes P450 by components of Ginkgo biloba

  2004cited by this paper
• Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity.

  2004influential reference
• The Inhibitory Effects of Herbal Components on CYP2C9 and CYP3A4 Catalytic Activities in Human Liver Microsomes

  2004cited by this paper
• In Vitro Interaction of the HIV Protease Inhibitor Ritonavir with Herbal Constituents: Changes in P-gp and CYP3A4 Activity

  2004cited by this paper
• The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy–6H–dibenzopyran–6– one derivatives by the colonic microflora of healthy humans

  2004cited by this paper
• TWO MAJOR GRAPEFRUIT JUICE COMPONENTS DIFFER IN INTESTINAL CYP3A4 INHIBITION KINETIC AND BINDING PROPERTIES

  2004cited by this paper
• Isolation of cytochrome P450 inhibitors from strawberry fruit, Fragaria ananassa.

  2004cited by this paper
• Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions

  2004cited by this paper
• Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice

  2003cited by this paper
• Exposure‐Dependent Inhibition of Intestinal and Hepatic CYP3A4 In Vivo by Grapefruit Juice

  2003cited by this paper
• Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract.

  2003cited by this paper
• Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer

  2002cited by this paper
• In vitro gastrointestinal digestion study of pomegranate juice phenolic compounds, anthocyanins, and vitamin C.

  2002cited by this paper
• Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans.

  2002cited by this paper
• In Vitro, Pharmacokinetic, and Pharmacodynamic Interactions of Ketoconazole and Midazolam in the Rat

  2002cited by this paper
• Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice.

  2002cited by this paper
• Inhibition of CYP3A‐mediated oxidation in human hepatic microsomes by the dietary derived complex phenol, gallic acid

  2002cited by this paper
• Drug interactions with grapefruit juice: an update.

  2001cited by this paper
• Effects of a water-soluble extract of rosemary and its purified component rosmarinic acid on xenobiotic-metabolizing enzymes in rat liver.

  2001cited by this paper
• Effect of grapefruit juice dose on grapefruit juice–triazolam interaction: repeated consumption prolongs triazolam half-life

  2000cited by this paper
• Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.

  2000cited by this paper
• Effects of the Antifungal Agents on Oxidative Drug Metabolism

  2000cited by this paper
• Drug-grapefruit juice interactions.

  2000cited by this paper
• Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin

  2000cited by this paper
• Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.

  2000cited by this paper
• Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity.

  2000cited by this paper
• Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects

  2000cited by this paper
• Effects of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site

  2000cited by this paper
• Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.

  2000cited by this paper
• Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: Effect of ketoconazole

  1999cited by this paper
• 6′,7′‐Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P‐glycoprotein

  1999cited by this paper
• Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir

  1998cited by this paper
• Grapefruit juice-drug interactions.

  1998cited by this paper
• Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.

  1997cited by this paper
• Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction.

  1997cited by this paper
• Effects of grapefruit juice ingestion – pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men

  1997cited by this paper
• Drug Interactions with Grapefruit Juice

  1997cited by this paper
• Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.

  1996cited by this paper
• Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.

  1996cited by this paper
• Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.

  1996cited by this paper
• Midazolam Hydroxylation by Human Liver Microsomes In Vitro: Inhibition by Fluoxetine, Norfluoxetine, and by Azole Antifungal Agents

  1996cited by this paper
• Disposition of intravenous and oral cyclosporine after administration with grapefruit juice

  1995cited by this paper
• Interaction between grapefruit juice and midazolam in humans

  1995cited by this paper
• Mechanism-based enzyme inactivators.

  1995cited by this paper
• Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid.

  1993cited by this paper
• Interaction of citrus juices with felodipine and nifedipine.

  1991cited by this paper
• Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

  1989cited by this paper
• Ethanol enhances the hemodynamic effects of felodipine.

  1989cited by this paper
• Mechanism-based enzyme inactivators.

  1984cited by this paper
• University of California

  1895cited by this paper

• Flavonoids and Furanocoumarins Involved in Drug Interactions

  2025cites this paper
• Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans.

  2025cites this paper
• The therapeutic potential of pomegranate in the prevention and management of noncommunicable diseases.

  2025cites this paper
• Antidepressant- and Anxiolytic-like Effects of Pomegranate: Is It Acting by Common or Well-Known Mechanisms of Action?

  2024cites this paper
• Interactions between grapefruit juice and psychotropic medications: an update of the literature and an original case series

  2024cites this paper
• Immunosuppression in solid organ-transplant recipients and impact on nutrition support.

  2023cites this paper
• Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials

  2023cites this paper
• Impact of Pomegranate Juice on the Pharmacokinetics of CYP3A4- and CYP2C9-Mediated Drugs Metabolism: A Preclinical and Clinical Review

  2023influential citation
• Pomegranate-specific natural compounds as onco-preventive and onco-therapeutic compounds: Comparison with conventional drugs acting on the same molecular mechanisms

  2023cites this paper
• A narrative review on clinical trials showing contraindicated drugs with grapefruit juice

  2023cites this paper
• Potential Cytochrome P450-mediated pharmacokinetic interactions between herbs, food, and dietary supplements and cancer treatments.

  2021cites this paper
• Effect of fresh pomegranate juice on the pharmacokinetic profile of artemether: An open-label, randomized, 2- period crossover study in healthy human volunteers.

  2021cites this paper
• Evidence for health properties of pomegranate juices and extracts beyond nutrition: A critical systematic review of human studies

  2021cites this paper
• Arzneimittelinteraktionen zwischen oralen TKI und pflanzlichen Präparaten

  2021cites this paper
• Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects.

  2020cites this paper
• Pomegranate Juice does not Affect the Bioavailability of Cyclosporine in Healthy Thai Volunteers

  2020cites this paper
• Assessment of Herb-Drug Interactions Based on the Pharmacokinetic Changes of Probe Drug, Midazolam.

  2020cites this paper
• THE IMPACT OF HERBAL MEDICINES USE IN PATIENTS UNDER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN RWANDA

  2020cites this paper
• Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study

  2020cites this paper
• In vitro–in vivo extrapolation of metabolic clearance using human liver microsomes: factors showing variability and their normalization

  2020cites this paper
• Health-Promoting Perspectives of Fruit-Based Functional Energy Beverages

  2019cites this paper
• Interaction of Cyclosporine A with Pomegranate Juice and Its Potential Nephroprotective Effect in Rats

  2019cites this paper
• Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review

  2018cites this paper
• Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit‐like pharmacokinetic interaction clinically

  2017cites this paper
• Effect of Low‐Furanocoumarin Hybrid Grapefruit Juice Consumption on Midazolam Pharmacokinetics

  2017cites this paper
• Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial

  2017cites this paper
• Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models

  2016cites this paper
• Anti-Cancer Activity of Pomegranate and its Biophenols; General Review

  2016cites this paper
• Mechanistic Modeling to Predict Midazolam Metabolite Exposure from In Vitro Data

  2016influential citation
• Pomegranate juice does not affect the disposition of simvastatin in healthy subjects

  2016cites this paper
• INFLUENCE OF POMEGRANATE JUICE ON THE CYP3A4-MEDIATED METABOLISM AND P-GLYCOPROTEIN MEDIATED TRANSPORT OF SAQUINAVIR IN VIVO AND EX VIVO MODELS

  2016cites this paper
• Dental Sedation in Children

  2015cites this paper
• Tropical Punch Packing a Real Knockout

  2015cites this paper
• ASSESSMENT OF THE GENOTOXIC AND MUTAGENIC EFFECT OF AL-TAIF POMEGRANATE (PUNICA GRANATUM L) PEEL EXTRACT ALONE AND COMBINED WITH MALATHION AND ATRAZINE PESTICIDES IN LIVER OF MALE ALBINO MICE

  2015cites this paper
• Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy

  2015cites this paper
• Efficacy and Safety of Pomegranate Medicinal Products for Cancer

  2015cites this paper
• Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot study.

  2014cites this paper
• Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?

  2014cites this paper
• Assessment of Intestinal Availability (FG) of Substrate Drugs of Cytochrome P450s by Analyzing Changes in Pharmacokinetic Properties Caused by Drug–Drug Interactions

  2014cites this paper
• Microsoft Word-64447191-file00.docx

  2014cites this paper
• A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data

  2014cites this paper
• Potentially significant versus clinically significant drug interactions: pomegranate juice as a case in point.

  2014cites this paper
• POMEGRANATE JUICE AFFECTS ON PHARMACOKINETIC PARAMETERS OF METRONIDAZOLE BY USING HPLC-MS

  2014cites this paper
• Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations

  2014cites this paper
• Pomegranate Health Care Professional Information Scientific

  2014cites this paper
• APPLICATIONS OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELLING TO PREDICTION OF THE LIKELIHOOD OF METABOLIC DRUG INTERACTIONS IN PAEDIATRIC POPULATION AND STUDYING DISPARITIES IN PHARMACOKINETICS BETWEEN CHILDREN AND ADULTS

  2014cites this paper
• Pomegranate Supplementation Protects against Memory Dysfunction after Heart Surgery: A Pilot Study

  2013cites this paper
• Is pomegranate juice a potential perpetrator of clinical drug–drug interactions? Review of the in vitro, preclinical and clinical evidence

  2013influential citation
• Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers

  2013cites this paper
• Effect of blueberry juice on clearance of buspirone and flurbiprofen in human volunteers.

  2013cites this paper
• Integrated Approaches to Identify and Predict Pharmacokinetic-Based Dietary Substance-Drug Interactions

  2013cites this paper
• Pomegranate-containing products and tacrolimus: a potential interaction.

  2013cites this paper
• A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat

  2013cites this paper
• Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

  2012cites this paper
• Pomegranate Juice and Pomegranate Extract Do Not Impair Oral Clearance of Flurbiprofen in Human Volunteers: Divergence From In Vitro Results

  2012cites this paper
• Evaluation of limited sampling models for prediction of oral midazolam AUC for CYP3A phenotyping and drug interaction studies

  2012cites this paper
• Herb–Drug and Food–Drug Interactions

  2012cites this paper
• Punica granatum

  2012cites this paper
• Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health

  2011cites this paper
• Antioxidant and antiatherogenic effects of pomegranate.

  2011cites this paper
• The effect of grapefruit juice on drug disposition

  2011cites this paper
• Pomegranate as a functional food and nutraceutical source.

  2011cites this paper
• Effect of 2 weeks' consumption of pomegranate juice on the pharmacokinetics of a single dose of midazolam: an open-label, randomized, single-center, 2-period crossover study in healthy Japanese volunteers.

  2011cites this paper
• The Bioactivity of Pomegranate: Impact on Health and Disease

  2011cites this paper
• Mitotane has a strong and a durable inducing effect on CYP3A4 activity.

  2011cites this paper
• Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model

  2011cites this paper
• Effect of commonly consumed botanicals on drug efflux across intestinal epithelial cells and excised tissues.

  2011cites this paper
• Physiologically Based Pharmacokinetic Modeling of Intestinal First-Pass Metabolism of CYP3A Substrates with High Intestinal Extraction

  2011cites this paper
• The effects of pomegranate juice consumption on blood pressure and cardiovascular health.

  2011cites this paper
• Influence of dietary substances on intestinal drug metabolism and transport.

  2010cites this paper
• Contribution of intestinal cytochrome p450-mediated metabolism to drug-drug inhibition and induction interactions.

  2010cites this paper
• Pomegranate in Human Health: An Overview

  2010cites this paper
• Marginal increase of sunitinib exposure by grapefruit juice

  2010cites this paper
• Grapefruit juice, lyophilized grapefruit juice, and powdered whole grapefruit inhibit cytochrome P450-mediated triazolam hydroxylation by beagle dog liver microsomes.

  2010cites this paper
• Herb–drug pharmacokinetic interactions reviewed

  2010cites this paper
• Prostate Cancer, Phytochemicals, Long-Chain Omega-3 Fatty Acids and Oxidative Stress

  2009cites this paper
• Clinical pharmacology of the tyrosine kinase inhibitors imatinib and sunitinib

  2009cites this paper
• Potential Interaction Between Pomegranate Juice and Warfarin

  2009cites this paper
• Clinically irrelevant effect of Grapefruit Juice on the steady-state sunitinib exposure

  2009cites this paper
• Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase.

  2009cites this paper
• Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects.

  2009cites this paper
• Identification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in Humans

  2009cites this paper
• Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1.

  2009cites this paper
• Grapefruit and Other Fruit Juices Interactions with Medicines

  2009cites this paper
• Comment on safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size.

  2008cites this paper
• Grapefruit juice-drug interaction studies as a method to assess the extent of intestinal availability: utility and limitations.

  2008cites this paper
• Ritonavir Greatly Impairs CYP3A Activity in HIV Infection With Chronic Viral Hepatitis

  2008cites this paper
• Potential role of intestinal first-pass metabolism in the prediction of drug–drug interactions

  2008cites this paper
• Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies.

  2008cites this paper
• Therapeutic applications of pomegranate (Punica granatum L.): a review.

  2008cites this paper
• PROPRIETARY BOTANICAL FOOD PRODUCT SCIENTIFIC AND CLINICAL MONOGRAPH FOR POM WONDERFUL ® POMEGRANATE JUICE

  2008cites this paper
• Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies

  2008cites this paper
• Holistic Approaches to Prostate Cancer

  2008cites this paper
• Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size.

  2008cites this paper
• The use of herbal medicine by AIDS patients from Hospital Universitário de Brasília, Brazil (La utilización de hierbas medicinales por pacientes con SIDA del Hospital Universitario de Brasilia, Brasil)

  2008cites this paper
• Interaction of Herbal Constituents with Cytochrome P450 Enzymes

  2007cites this paper
• Granatapfel: Prävention und adjuvante Ernährungstherapie bei Krebserkrankungen

  2007cites this paper
• Granatapfel: Prävention und adjuvante Ernährungstherapie bei Herz-Kreislauf-Erkrankungen

  2007cites this paper